ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Our results establish a putative link between BCR-ABL1 TK activity-contingent enhancement of CBY1 SUMOylation and inactivation of JNK/14-3-3σ associated with the BCR-ABL1 TK activity of CML.